FindTrial
Sign In

A randomized controlled study of stellate ganglion block in the treatment of patients with paroxysmal sympathetic hyperactivity

A randomized controlled study of stellate ganglion block in the treatment of patients with paroxysmal sympathetic hyperactivity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097782
Enrollment
Unknown
Registered
2025-02-25
Start date
2023-11-17
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal sympathetic hyperactivity syndrome

Interventions

Experimental group:Drug therapy combined with stellate ganglion block
Control group:Drug therapy alone

Sponsors

The Second Hospital,University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 years old gender unlimited; 2.PSH-AM>=8; 3.Obtain a written informed consent signed by the subject himself or his legal representative;

Exclusion criteria

Exclusion criteria: 1.History of hypertension; 2.Patients with sepsis, encephalitis, pulmonary embolism, substance withdrawal, pheochromocytoma, carotid sinus injury, and acute baroreceptor failure; 3.The subjects themselves or their legal representatives refused to participate in the clinical trial;

Design outcomes

Primary

MeasureTime frame
PSH-AM score;CFS score;DLT score;—

Secondary

MeasureTime frame
Duration of PSH;Blood levels of norepinephrine;Blood levels of adrenaline;Blood levels of cortisol;—

Countries

China

Contacts

Public ContactWang Tao

The Second Hospital,University of South China

2012020051@usc.edu.cn+86 734 8899684

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026